gleevec
5 Take-Home Points From India’s Historic Novartis Patent Case
The Indian Supreme Court ruling dismissing a patent application by Novartis for a new version of its leukemia drug raises five important points, writes Arvind Subramanian.
Novartis Loses Historic India Patent Case On Cancer Drug Glivec
After a seven year protracted battle, the Supreme Court of India has rejected a patent application by Swiss pharma giant Novartis for an updated version of its blockbuster drug.
Dr. Alex Matter Awarded 2013 Szent-Györgyi Prize For Progress In Cancer Research
Dr. Alex Matter, father of targeted cancer therapies, will receive the 8th Szent-Györgyi Prize for Progress in Cancer Research this Friday in Washington, DC.
